NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/24/2026
Back to search
Official data from USPTO
EVAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
03/25/2026
Trademark type
Combined
Nice classes
42
Filing date
07/16/2024
Registration date
03/24/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2026
Last transaction
03/25/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/01/2024
First use in commerce
07/01/2024
Drawing code
3
Owner type
16
Owner location
Saint Paul, MN, US
Examiner
HETZEL, DANNEAN
Law office
L60
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a circle with the sigma symbol inside the circle and the word "EVAL" after the circle.
Holders and representatives
Holders
EVAL Health LLC
Representatives
EVAL Health LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Platform as a service (PaaS) featuring HIPAA-compliant software platforms using artificial intelligence and machine learningdesigned for healthcare providers to translate peer-reviewed medical research into low-code clinical apps and clinical decision support tools for use at the point of care; Software as a service (SaaS) services featuring secureregulatory-compliantweb-based and mobile software for low-code clinical appsenabling clinicians and healthcare organizations to evaluate medical conditionsrecommend evidence-based treatmentsimplement published medical guidelinesall derived from standardized clinical research data
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/03/2026
PUBO
PUBLISHED FOR OPPOSITION
02/03/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/28/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/13/2026
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/02/2026
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/01/2025
GNSL
LETTER OF SUSPENSION E-MAILED
07/01/2025
CNSL
SUSPENSION LETTER WRITTEN
07/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/01/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/19/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/01/2025
GNSL
LETTER OF SUSPENSION E-MAILED
05/01/2025
CNSL
SUSPENSION LETTER WRITTEN
05/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/01/2025
ALIE
ASSIGNED TO LIE
05/01/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/17/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/11/2025
GNSL
LETTER OF SUSPENSION E-MAILED
04/11/2025
CNSL
SUSPENSION LETTER WRITTEN
04/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/09/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/09/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/06/2025
GNRT
NON-FINAL ACTION E-MAILED
02/06/2025
CNRT
NON-FINAL ACTION WRITTEN
02/06/2025
DOCK
ASSIGNED TO EXAMINER
02/06/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/05/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/05/2025
MAFR
APPLICATION FILING RECEIPT MAILED
07/16/2024
NWAP
NEW APPLICATION ENTERED
07/16/2024
Continuous trademark protection
Get notified about every new filing that threatens EVAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.